228 related articles for article (PubMed ID: 16829825)
1. The efficacy of photodynamic therapy combined with intravitreal triamcinolone acetonide (TA) for treatment of occult choroidal neovascularization secondary to age-related macular degeneration.
Ho TC
Retina; 2006; 26(6):714; author reply 715. PubMed ID: 16829825
[No Abstract] [Full Text] [Related]
2. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
[TBL] [Abstract][Full Text] [Related]
3. Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.
Nicolò M; Ghiglione D; Lai S; Nasciuti F; Cicinelli S; Calabria G
Retina; 2006 Jan; 26(1):58-64. PubMed ID: 16395140
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization.
Degenring RF; Jonas JB
Acta Ophthalmol Scand; 2005 Oct; 83(5):621. PubMed ID: 16188006
[No Abstract] [Full Text] [Related]
7. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
Chaudhary V; Mao A; Hooper PL; Sheidow TG
Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
[TBL] [Abstract][Full Text] [Related]
8. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone.
Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):245-54. PubMed ID: 17674020
[TBL] [Abstract][Full Text] [Related]
10. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
Ergun E; Maár N; Ansari-Shahrezaei S; Wimpissinger B; Krepler K; Wedrich A; Stur M
Am J Ophthalmol; 2006 Jul; 142(1):10-16. PubMed ID: 16815246
[TBL] [Abstract][Full Text] [Related]
12. Combined photodynamic therapy and intravitreal triamcinolone injection for choroidal neovascularization in Best disease.
Nóbrega M; Bortolotto C; Farah M
Can J Ophthalmol; 2007 Oct; 42(5):761-2. PubMed ID: 17891211
[No Abstract] [Full Text] [Related]
13. The temporal sequence of combined intravitreal triamcinolone acetonide and photodynamic therapy for exudative age-related macular degeneration.
Roth DB; Kulkarni KM; Feuer WJ
Ophthalmic Surg Lasers Imaging; 2008; 39(1):12-6. PubMed ID: 18254345
[TBL] [Abstract][Full Text] [Related]
14. Choroidal neovascularization in sorsby fundus dystrophy treated with photodynamic therapy and intravitreal triamcinolone acetonide.
Peiretti E; Klancnik JM; Spaide RF; Yannuzzi L
Retina; 2005; 25(3):377-9. PubMed ID: 15805922
[No Abstract] [Full Text] [Related]
15. Photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: a randomized clinical trial.
Maberley D;
Ophthalmology; 2009 Nov; 116(11):2149-57.e1. PubMed ID: 19748675
[TBL] [Abstract][Full Text] [Related]
16. Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration.
; Gilson MM; Bressler NM; Jabs DA; Solomon SD; Thorne JE; Wilson DJ
Ophthalmology; 2007 Sep; 114(9):1713-21. PubMed ID: 17822977
[TBL] [Abstract][Full Text] [Related]
17. Triple therapy of intravitreal triamcinolone, photodynamic therapy, and pegaptanib sodium for choroidal neovascularization.
Liggett PE; Colina J; Chaudhry NA; Tom D; Haffner G
Am J Ophthalmol; 2006 Dec; 142(6):1072-4. PubMed ID: 17157599
[TBL] [Abstract][Full Text] [Related]
18. Perspectives on verteporfin therapy combined with intravitreal corticosteroids.
Schmidt-Erfurth U; Michels S; Augustin A
Arch Ophthalmol; 2006 Apr; 124(4):561-3. PubMed ID: 16606885
[No Abstract] [Full Text] [Related]
19. Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone.
Michels S; Aue A; Simader C; Geitzenauer W; Sacu S; Schmidt-Erfurth U
Am J Ophthalmol; 2006 Feb; 141(2):396-398. PubMed ID: 16458709
[TBL] [Abstract][Full Text] [Related]
20. Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration.
Arevalo JF; Garcia RA; Mendoza AJ
Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1180-5. PubMed ID: 15906068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
